Description of image

We are a cancer epigenomics lab based in the Department of Pharmacology at Case Western Reserve University, School of Medicine. Our research is dedicated to uncovering novel fundamental mechanisms underlying gene expression in cancers. We utilize advanced multi-omics technologies, including high-throughput CRISPR screening, single-cell transcriptomics, epigenomics, proteomics, and metabolomics to comprehensively detail the oncogenic mechanisms of transcription factors and identify therapeutic targets for treatment.
  • We are currently seeking postdocs, students, and staff to join our team. For more information, please view our available opportunities.